England’s former national cancer director has endorsed the 18-week target for referrals to treatment, a key benchmark in the NHS’s efforts to reduce delays in cancer care. The move comes amid ongoing debates over whether the current system can consistently meet patient needs within tight deadlines. Supporters argue the target helps ensure timely access to life-saving interventions, while critics question its feasibility under stretched resources. The endorsement adds weight to discussions about balancing speed with quality in healthcare delivery.
An 18‑week referral‑to‑treatment target has been backed by England's former national cancer director.
